After you, corporate presentation press results ir.lifemd.com. updated good an Thank and second posted our and the afternoon, website announcing market our release at on issued quarter a we closed, everyone.
Our established in the second continuing momentum performance quarter. first quarter the was strong,
demonstrated achieved telehealth ahead double-digit growth core and revenue we business Our schedule. again positive once flow cash free sequential of
about management Additionally, have results far GLP-X weight successfully in Wegovy, we rolled patients moment. Mounjaro. out I'll a The early surpassed more program, access Ozempic, speak helps which this our medications, expectations. and such as our
to from $XXX revenue $XXX guidance of weight our XXXX are existing $XXX we and to Given million telehealth raising opportunity the the continued us tremendous our million $XXX strong the performance of management million. ahead up in full-year previous million, to business,
team, time, our the are guidance are business. which we account clinical vital marketing in adjusted same for EBITDA and rapidly to this reducing our the scaling At near-term investments to modestly
in and our off XXXX. investments and bottom these expect pay to beginning both management lines to top substantially being weight accretive foresee quickly our We program
meaningful our For the that focused for value believe on remainder year, to will key LifeMD remains four shareholders. of the initiatives drive we continue
direct-to-consumer we program which the is rolled launch this of our April. First out weight past management officially
and of strongest still our is incredible annual of of short business management to telehealth an economics very translating the unit over start subscribers million recurring In in offerings As early, an we've the while rate any to with off period, active a X,XXX I mentioned weight amassed over $X run patient revenue. to date.
XXX QX We scale differentiated XXX goal offering of to to We're this increasing our competition. per approximately day the patients of patients aiming to with offering day the average is per by new patients from rapidly truly year-end. our XXX believe
offering it's services, a apart and it's access management to weight care patients. as comprehensive integrated GLP-X for with blend a selling lab fully for lifestyle diagnostics, of not GLP-X our holistic program Our physician visits, primary Therapeutics. package a vehicle eligible stands is that work, Instead, just support
LifeMD subscribed services, month. at per $XXX approximately these For quarterly patients
comprehensive gain on requiring conditions. our can synchronous visits and care provide we patients to with data by Additionally, valuable physicians, coexisting our virtual
significantly could and XXXX program enhance forecast EBITDA. this preliminary Our our that suggests revenues
in we management, make and in offers with launched in national Second, quarter, two driven partnerships capabilities wellness, progress to health, companies during we segments. management securing telemedicine LifeMD weight building continued the unique the weight partnerships, off exciting significant the high-value
unique combine be to coaching excited our with telehealth very and patient outcomes. are core competencies these to aligned nutritional with to their We capabilities premier maximize tremendous partners
future in jumping can these believe BXB as point We pilot for area. initial off serve this extremely partnerships an partnerships valuable
group. LifeMD's ahead, our ample unique Looking expand affiliated these the upon to partnerships of and telehealth medical see and opportunity we new leveraging other platform capabilities
our top insurance substantial key Initially, accept represent year. preliminary valuable we from begun We team work these virtual of on Medicare our end providers efforts by primary expansion within and states the care primary acceptance. opportunities accepting progress also believe third of regulatory we've towards experts, aim and platform. XX we're significant a within compliance care the our the insurance to For Alongside initiative, platform. making private private insurance for
lifestyle Health businesses existing anchored health-care by our to subsidiary brand, Finally, continued WorkSimpli and RexMD, Men's our outperform. our
to we considerable profitable high-growth last to only ad guided on year, highly but investment As in XXXX the in on patient and spent spend unit areas, we refining time also economics not RexMD cohorts. focus
of to back in the While deliver in required revenue such a take XXXX returned and to quarter momentum. that this terms continue against sequential we growth, XXXX us step growth first small in to of
quarter up growth. sequential and second consecutive XX% for quarter Second sequentially RexMD double-digit the represents revenue was of
We the balance deliver with for lifestyle for sequential XX% single-digit growth revenue businesses. high expect on of basis growth year-over-year existing go-forward to exceeding our XXXX a
XX% costs. Our corporate remain to versus in deliver with profitable continued WorkSimpli growing XX% prior strong These businesses incredibly and results. during subsidiary quarter, second both year. the of growing XX% revenue including the achieving net margins subscribers excess contribution with
turn CFO, of With over to Marc summary financial Marc? will a who that, provide I'll Benathen, our the results. call our